Better Therapeutics Analyst Ratings
Better Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2022 | 842.76% | Chardan Capital | $17 → $14 | Maintains | Buy |
| 07/29/2022 | 1044.78% | Chardan Capital | $15 → $17 | Maintains | Buy |
| 03/16/2022 | 1112.12% | Chardan Capital | $17 → $18 | Maintains | Buy |
| 11/24/2021 | 1044.78% | Chardan Capital | → $17 | Initiates Coverage On | → Buy |
| 11/10/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 11/15/2022 | 842.76% | 查尔丹资本 | $17 → $14 | 维护 | 买 |
| 07/29/2022 | 1044.78% | 查尔丹资本 | $15 → $17 | 维护 | 买 |
| 03/16/2022 | 1112.12% | 查尔丹资本 | $17 → $18 | 维护 | 买 |
| 11/24/2021 | 1044.78% | 查尔丹资本 | → $17 | 开始承保 | →购买 |
| 11/10/2021 | — | 考恩公司 | 开始承保 | →跑赢大盘 |
What is the target price for Better Therapeutics (BTTX)?
Better Treeutics(BTTX)的目标价格是多少？
The latest price target for Better Therapeutics (NASDAQ: BTTX) was reported by Chardan Capital on November 15, 2022. The analyst firm set a price target for $14.00 expecting BTTX to rise to within 12 months (a possible 842.76% upside). 4 analyst firms have reported ratings in the last year.
查尔丹资本于2022年11月15日报道了Better Treateutics(纳斯达克：BTTX)的最新目标价。这家分析公司将目标价定为14美元，预计BTTX将在12个月内上涨至(可能上涨842.76%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Better Therapeutics (BTTX)?
最新的分析师对Better Treeutics(BTTX)的评级是什么？
The latest analyst rating for Better Therapeutics (NASDAQ: BTTX) was provided by Chardan Capital, and Better Therapeutics maintained their buy rating.
对Better Treateutics(纳斯达克代码：BTTX)的最新分析师评级由查尔丹资本提供，Better Treateutics维持买入评级。
When is the next analyst rating going to be posted or updated for Better Therapeutics (BTTX)?
下一次分析师评级将于何时发布或更新，以改善治疗(BTTX)？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Better Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Better Therapeutics was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.
分析师在进行了广泛的研究后得出股票评级，其中包括查看公共财务报表，与Better Treeutics的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。上一次对Better Treeutics的评级是在2022年11月15日提交的，所以你应该预计下一次评级将在2023年11月15日左右提供。
Is the Analyst Rating Better Therapeutics (BTTX) correct?
分析师对Better Treeutics(BTTX)的评级正确吗？
While ratings are subjective and will change, the latest Better Therapeutics (BTTX) rating was a maintained with a price target of $17.00 to $14.00. The current price Better Therapeutics (BTTX) is trading at is $1.49, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Better Treeutics(BTTX)评级保持不变，目标价在17.00美元至14.00美元之间。目前Better Treateutics(BTTX)的交易价格为1.49美元，超出了分析师的预测范围。